Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
Check out the latest news on antibody technology, including updates on antibody testing, antibody analytics, and monoclonal antibody treatment.
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
A biopharmaceutical company developing anti-inflammatory therapeutics announced today (July 26) that it is going to…
A drug candidate for unresectable or metastatic breast cancer has been accepted by the US…
A phase 1 trial to investigate a drug for treating people with advanced malignant neoplasms…
The Belgian company Agomab Therapeutics has topped up its Series B round by $40.5 million…
A company from South Korea has signed a research collaboration and license agreement with a…
A biologics license application has been submitted to the US Food and Drug Administration (FDA)…
A new facility dedicated to the advancement of medical research and drug development opened its…
Scancell Holdings plc, which develops immunotherapies for the treatment of cancer and infectious disease, has…
Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney…
French biotech company ImCheck has announced funding of €96 million ($101.5 million) to investigate antibody…
Funding of £2.4 million ($2.9 million) has been secured by UK-based company, Spirea Limited, to…